Jean‐Baptiste Assié
Inserm · 138 works · 1,595 citations · h-index 21
Top works
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
- Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis
- Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
- Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
- Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
- Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients
- The value of open-source clinical science in pandemic response: lessons from ISARIC
- Neurological manifestations of COVID-19 in adults and children
- Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials
- Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases
- First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
- Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
- Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study
- Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
- Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
- Double immune checkpoint inhibitor therapy for unresectable pleural mesothelioma rarely induces hyperprogressive disease: a case report
- Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis
- FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer